The WHO designation makes the fast, compact, and fully automated instrument eligible for use in CD4 monitoring and related UN procurement tenders.
Making the transition from manual to automated blood analysis supports the hospital’s efforts to become a Level II trauma center.
Clinical labs should ensure that the components they use in developing and performing laboratory-developed tests are themselves consistent in quality and other attributes necessary to produce an accurate report.
The next-generation sequencing based molecular test detects genomic variations in 213 genes related to familial cardiovascular diseases.
Each 192-gene panel includes 180 topic-specific probes and 12 universal housekeeping genes.
Without requiring blood culture, the T2Bacteria panel enables rapid, sensitive detection of six clinically relevant sepsis-causing bacteria.
UV lights in the cabinet are used to denature nucleic acids in 5 to 30 minutes, making them unsuitable for amplification.
Locking doors protect 6.5 cubic feet of storage space to secure users’ valuable items.
The unit features a stainless steel interior with continuously backwelded seams, stainless steel exterior with a brushed finish, and 4-inch insulated walls.
With support from the US Centers for Disease Control and Prevention, DC’s public health agencies and healthcare facilities will examine the occurrence of “superbugs” in a first-of-its-kind citywide evaluation.
University of Utah chemists have discovered a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
Early data suggests the test’s clinical potential for guiding anti-PD-1 therapy.
The Defense Health Agency has added 32 tests to its demonstration project reviewing tests not examined by FDA to determine whether they are safe and effective for use.
The fully automated hematoxylin and eosin tissue staining system eliminates the use of xylene and alcohol, reducing technician exposure to harmful chemicals.
The chip enables researchers to use droplet-based microfluidic methods to help explore the behavior of thousands of individual cells, providing a rapid and easy way to screen for new or cryptic cell types.
The assay enables rapid assessment of tissue-based biomarker expression across the full spectrum of clinical formalin-fixed, paraffin-embedded tissue samples without the need for lengthy rounds of assay optimization.
For the coming year, labs are expecting more regulatory challenges amid advancing technologies.
Launched in October, the program provides the essential first steps of a comprehensive approach to address the shortage of qualified laboratory professionals in the healthcare industry.
Qiagen developed GeneReader as a complete sample-to-insight next-generation sequencing solution, designed for any lab to deliver actionable results.
The system’s latest launch includes an advanced hematology module that offers improved visibility of critical data.